Literature DB >> 10598091

Detection of measles specific IgG in oral fluid using an FITC/anti-FITC IgG capture enzyme linked immunosorbent assay (GACELISA).

W Nigatu1, D J Nokes, F Enquselassie, D W Brown, B J Cohen, A J Vyse, F T Cutts.   

Abstract

An IgG antibody capture enzyme linked immunosorbent assay (GACELISA) for the detection of measles specific IgG in oral fluid was developed using an FITC/anti-FITC amplification system. The GACELISA was evaluated by testing paired oral fluid and serum samples from 787 subjects in an epidemiological study of measles in rural Ethiopia. Oral fluids were tested by GACELISA and corresponding serum samples by a sensitive indirect ELISA for measles IgG (Behring Enzygnost). By comparison with the serum measles IgG assay, the oral fluid GACELISA had a sensitivity of 97.4% (95% confidence intervals: 95.9, 98.2) and a specificity of 90.0% (81.9, 94.3), with no significant differences observed by age group. Total IgG concentrations were measured on a subset of 160 oral fluids by an in-house ELISA. This showed that false negative GACELISA results tended to occur in samples with low concentrations of total IgG, although the trend was not statistically significant. It is concluded that the overall performance of the GACELISA was satisfactory, showing close agreement to the serum ELISA, and has potential to serve as an easily transferable tool for large scale epidemiological studies as required for the World Health Organisation's programme for the global control of measles.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10598091     DOI: 10.1016/s0166-0934(99)00116-0

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  7 in total

1.  Evaluation of commercial assay detecting specific immunoglobulin g in oral fluid for determining measles immunity in vaccinees.

Authors:  Jacques R Kremer; Claude P Muller
Journal:  Clin Diagn Lab Immunol       Date:  2005-05

2.  Detection of measles- and mumps-specific IgG antibodies in paired serum and oral fluid samples from Norwegian conscripts.

Authors:  K Vainio; H H Samdal; G Anestad; E Wedege; D H Skutlaberg; K T Bransdal; R Mundal; I S Aaberge
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-02-22       Impact factor: 3.267

3.  Use of Saccharomyces cerevisiae-expressed recombinant nucleocapsid protein to detect Hantaan virus-specific immunoglobulin G (IgG) and IgM in oral fluid.

Authors:  Rasa Petraityte; Li Jin; Rashpal Hunjan; Ausra Razanskiene; Aurelija Zvirbliene; Kestutis Sasnauskas
Journal:  Clin Vaccine Immunol       Date:  2007-10-03

4.  Evaluation of a measles vaccine campaign by oral-fluid surveys in a rural Kenyan district: interpretation of antibody prevalence data using mixture models.

Authors:  E O Ohuma; E A Okiro; A Bett; J Abwao; S Were; D Samuel; A Vyse; N Gay; D W G Brown; D J Nokes
Journal:  Epidemiol Infect       Date:  2008-06-10       Impact factor: 2.451

5.  Measles vaccination coverage estimates from surveys, clinic records, and immune markers in oral fluid and blood: a population-based cross-sectional study.

Authors:  Kyla T Hayford; Mohammed S Shomik; Hassan M Al-Emran; William J Moss; David Bishai; Orin S Levine
Journal:  BMC Public Health       Date:  2013-12-20       Impact factor: 3.295

6.  Assessment of measles immunity among infants in Maputo City, Mozambique.

Authors:  Jagrati V Jani; Carol Holm-Hansen; Tufária Mussá; Arlinda Zango; Ivan Manhiça; Gunnar Bjune; Ilesh V Jani
Journal:  BMC Public Health       Date:  2008-11-12       Impact factor: 3.295

Review 7.  Measuring coverage in MNCH: design, implementation, and interpretation challenges associated with tracking vaccination coverage using household surveys.

Authors:  Felicity T Cutts; Hector S Izurieta; Dale A Rhoda
Journal:  PLoS Med       Date:  2013-05-07       Impact factor: 11.069

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.